Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether tifacogin is effective and safe in the
treatment of patients with severe community-acquired pneumonia.